SCHEMBL2229953

SCHEMBL2229953

Cc1cnc(Nc2ccccc2)nc1Nc1cc[c]cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 3/20 0.60
EGFR P00533 10/20 0.60
ITK Q08881 5/20 0.60
SYK P43405 2/20 0.58
BTK Q06187 7/20 0.56
JAK3 P52333 4/20 0.56
CDK2 P24941 3/20 0.55
IGF1R P08069 2/20 0.55
JAK2 O60674 2/20 0.55
GSK3B P49841 2/20 0.55
CDK1 P06493 2/20 0.55
PLK4 O00444 1/20 0.55
PDPK1 O15530 1/20 0.55
PRKD3 O94806 1/20 0.55
MAP4K4 O95819 1/20 0.55
NTRK1 P04629 1/20 0.55
INSR P06213 1/20 0.55
LCK P06239 1/20 0.55
FYN P06241 1/20 0.55
FES P07332 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10187818 0.91 AURKA (0.71) AURKAEGFRITKSYKBTK
SCHEMBL13166254 0.84 AURKA (0.66) AURKAEGFRITKSYKBTK
SCHEMBL10187765 0.81 JAK2 (0.69) AURKAEGFRITKSYKBTK
SCHEMBL29695644 0.81 CDK2 (0.64) AURKAEGFRITKSYKBTK
SCHEMBL270190 0.81 EGFR (0.54) AURKAEGFRITKSYKBTK
SCHEMBL13166126 0.80 SYK (0.67) AURKAEGFRITKSYKBTK
SCHEMBL12519548 0.80 SYK (0.67) AURKAEGFRITKSYKBTK
SCHEMBL12749854 0.80 SYK (0.63) AURKAEGFRITKSYKBTK
SCHEMBL11919318 0.78 EGFR (0.61) AURKAEGFRITKSYKBTK
SCHEMBL12519716 0.78 EGFR (0.70) AURKAEGFRITKSYKBTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2519235-A1 HETEROARYL COMPOUNDS AND USES THEREOF Avila Therapeutics, Inc. (US) 2012-11-07 EP disclosed
WO-2011090760-A1 HETEROARYL COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2011-07-28 WO disclosed